ShEEP Request for Seahorse Analyzer for Measuring Mitochondrial Respiration
ShEEP 请求使用 Seahorse 分析仪来测量线粒体呼吸
基本信息
- 批准号:9908873
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2020-09-30
- 项目状态:已结题
- 来源:
- 关键词:AfghanistanAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAnimal ModelAntimalarialsAntiparasitic AgentsAuditoryAwardBasic ScienceBrainCell Culture TechniquesCell modelCellsClinicClinicalClinical ResearchClinical TrialsCommunicable DiseasesConflict (Psychology)ConsumptionCultured CellsDevelopmentDrug EvaluationEnsureEnzymesEpilepsyEquipmentEvaluationExposure toFundingFutureGenus HippocampusGoalsHealthHealth ServicesHealth Services ResearchHealthcare SystemsHome environmentInjuryInterventionIraqK-Series Research Career ProgramsLaboratoriesLeadMalariaMalignant NeoplasmsMeasurementMeasuresMethodologyMethodsMissionMitochondriaModelingMultiple SclerosisMutationNeckNeurodegenerative DisordersNeuroprotective AgentsNeurosciencesOrganellesOutcome MeasureOutcomes ResearchOxygen ConsumptionParasitesParkinson DiseasePharmacotherapyProteinsRecording of previous eventsRehabilitation therapyReproducibilityResearchResearch PersonnelResearch Project GrantsResearch SupportResource SharingRespirationRoleScientistServicesSheepSiteSourceStromal CellsSuccinate DehydrogenaseTechnologyTissuesToxic effectToxoplasmosisTrainingTranslatingTranslationsTraumatic Brain InjuryUnited States Agency for Healthcare Research and QualityUnited States National Institutes of HealthUniversitiesVeteransWorkagent orangealcohol researchalpha Toxinanimal tissuebasebrain cellbrain tissuecancer cellcell typeclinical applicationclinical translationclinically relevantcooperative studydesignepidemiology studyexperienceimprovedinstrumentinterestmicroorganismneurorestorationoncologypre-clinicalpreclinical studyprogramsrecruitsquare foottargeted cancer therapyuser-friendly
项目摘要
Objectives: The objective of this equipment request is to obtain a state-of-the-art instrument to
measure mitochondrial function in order to serve the research needs of investigators at the VA
Portland Health Care System facility (VAPORHCS). In fiscal year 2018, VAPORHCS scientists
were successful in competing for over $32 million in research grants from the VA, NIH, DOD
and other sources. The VAPORHCS ranks 7th among all VAs nationwide in total research
funding. There are 10 career development award or K-award recipients currently being trained
here. Research is conducted in a total of 96,000 square feet of wet and dry lab space that
supports programs in basic science, clinical research, rehabilitation, health services,
cooperative studies, epidemiology and outcomes research. VAPORHCS is home to Centers of
Excellence funded by the VA in Auditory Research and Health Services Research, and an NIH-
funded Alcohol Research Center. Clinical programs awarded to the VAPORHCS include a
NODES, NAVIGATE, MVP recruiting site, MIRECC, PADRECC, Centers for Multiple Sclerosis
and Epilepsy, and Centers funded by QUERI and AHRQ.
Plan: The plan is to obtain a Seahorse analyzer and locate it in the Portland VA facility to serve
as a shared resource for VA investigators whose research involves measurement of
mitochondrial respiration. Planned studies by the six VA-funded investigators include:
measurement of mitochondrial respiration for: 1) the evaluation of candidate therapies in cell
culture and animal models of Alzheimer’s disease, 2) evaluation of antimalarial drugs, 3)
evaluation of drugs for the treatment of toxoplasmosis, 4) evaluation of the functional
significance of succinate dehydrogenase mutations in stromal cell cancer cells, 5) evaluation of
candidate therapies in a toxin model of Parkinson’s disease, and 6) evaluation of the effects of
traumatic brain injury upon brain cell mitochondria. Once the instrument is in place, additional
investigators are expected to take advantage of it.
Methods: The tissue source for the measurements will vary across the respective laboratories,
with mitochondrial respiration measured in cultured cells, in parasites, and in mitochondria
isolated from brain tissue, depending on the research program. The Seahorse analyzer
measures basal and maximum mitochondrial energy consumption and a number of other
metrics are calculated from these values.
Clinical relevance: The investigators participating in this request perform research which is
intended to be translated to clinical application, and several have advanced their preclinical
work to clinical trials, including treatments for Alzheimer’s disease, cancer, malaria,
toxoplasmosis, and traumatic brain injury. The research supported by this instrument
consequently has a high likelihood of leading to interventions to improve the health of veterans.
Relevance to the VA’s mission: The treatment of neurodegenerative disease, cancer,
infectious disease, and traumatic brain injury are all important for the VA’s mission. Two of the
conditions under study are especially relevant to the VA: Parkinson’s disease is a service-
connected illness for veterans with a history of exposure to Agent Orange exposure and
traumatic brain injury is the signature injury for veterans of recent conflicts in Iraq and
Afghanistan.
目的:本设备申请的目的是获得最先进的仪器,
测量线粒体功能,以满足VA研究人员的研究需求
波特兰卫生保健系统机构(VAPORHCS)。在2018财年,VAPORHCS科学家
成功地从退伍军人管理局、国家卫生研究院、国防部获得了超过3200万美元的研究赠款
和其他来源。VAPORHCS在全国所有VA中的总研究排名第七
经费目前正在培训10名职业发展奖或K奖获得者
这里.研究在总共96,000平方英尺的干湿实验室空间中进行,
支持基础科学,临床研究,康复,卫生服务,
合作研究、流行病学和成果研究。VAPORHCS是家庭中心,
卓越由VA资助的听觉研究和卫生服务研究,以及NIH-
酒精研究中心。授予VAPORHCS的临床项目包括
NODES、NAVIGATE、MVP招募网站、MIRECC、PADRECC、多发性硬化中心
以及由QUERI和AHRQ资助的中心。
计划:计划是获得一台Seahorse分析仪,并将其放置在波特兰VA设施中,
作为VA调查人员的共享资源,其研究涉及测量
线粒体呼吸由VA资助的六名研究人员计划进行的研究包括:
线粒体呼吸的测量用于:1)评估细胞中的候选疗法
阿尔茨海默病的培养和动物模型,2)抗疟药物的评价,3)
用于治疗弓形虫病的药物的评价,4)用于治疗弓形虫病的药物的功能评价,
间质细胞癌细胞中琥珀酸脱氢酶突变的意义,5)评估
在帕金森病的毒素模型中的候选疗法,和6)评价
创伤性脑损伤对脑细胞线粒体的影响。一旦文书到位,
调查人员将利用这一点。
方法:用于测量的组织来源将在各个实验室中有所不同,
在培养细胞、寄生虫和线粒体中测量线粒体呼吸
从脑组织中分离出来,这取决于研究项目。Seahorse分析仪
测量基础和最大线粒体能量消耗以及一些其他
从这些值计算度量。
临床相关性:参与本申请的研究者进行的研究
旨在转化为临床应用,有几个已经推进了其临床前
致力于临床试验,包括治疗阿尔茨海默病,癌症,疟疾,
弓形虫病和脑外伤该仪器支持的研究
因此,很有可能采取干预措施,改善退伍军人的健康。
与退伍军人事务部的使命的相关性:神经退行性疾病,癌症,
传染病和创伤性脑损伤对退伍军人事务部的使命都很重要。两
研究中的条件与VA特别相关:帕金森病是一种服务-
有接触过橙子剂的退伍军人的相关疾病,
创伤性脑损伤是最近伊拉克冲突中退伍军人的标志性损伤,
阿富汗
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSEPH F QUINN其他文献
JOSEPH F QUINN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSEPH F QUINN', 18)}}的其他基金
A novel estrogen modulator for the treatment of Alzheimer's disease
一种用于治疗阿尔茨海默病的新型雌激素调节剂
- 批准号:
9898288 - 财政年份:2018
- 资助金额:
-- - 项目类别:
A novel estrogen modulator for the treatment of Alzheimer's disease
一种用于治疗阿尔茨海默病的新型雌激素调节剂
- 批准号:
10158406 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Biological signatures of the cognitive effects of Centella asiatica
积雪草认知影响的生物学特征
- 批准号:
9563219 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Targeting tau pathology with copper-modulating strategies in Alzheimers disease
通过铜调节策略针对阿尔茨海默病的 tau 病理学
- 批准号:
8634332 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Targeting tau pathology with copper-modulating strategies in Alzheimers disease
通过铜调节策略针对阿尔茨海默病的 tau 病理学
- 批准号:
9339519 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Targeting tau pathology with copper-modulating strategies in Alzheimers disease
通过铜调节策略针对阿尔茨海默病的 tau 病理学
- 批准号:
8974327 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Targeting tau pathology with copper-modulating strategies in Alzheimers disease
通过铜调节策略针对阿尔茨海默病的 tau 病理学
- 批准号:
8815001 - 财政年份:2014
- 资助金额:
-- - 项目类别:














{{item.name}}会员




